Erimos Pharma 
Welcome,         Profile    Billing    Logout  
 3 Products   47 Diseases  3 Products   1 Trial   36 News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
terameprocol oral (EM-1421 oral) / Erimos Pharma
NCT02575794: Terameprocol in Treating Patients With Recurrent High Grade Glioma

Completed
1
20
US
Terameprocol, 1,1'-(2,3-Dimethyl-1,4-butanediyl)bis(3,4-dimethoxybenzene), EM-1421, M4N, tetra-O-methyl NDGA, Tetra-O-methyl Nordihydroguaiaretic Acid, TMNDGA, Pharmacological Study, Pharnacological Study
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Erimos Pharmaceuticals, National Cancer Institute (NCI)
High Grade Glioma (III or IV)
09/23
10/23
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
terameprocol oral (EM-1421 oral) / Erimos Pharma
NCT02575794: Terameprocol in Treating Patients With Recurrent High Grade Glioma

Completed
1
20
US
Terameprocol, 1,1'-(2,3-Dimethyl-1,4-butanediyl)bis(3,4-dimethoxybenzene), EM-1421, M4N, tetra-O-methyl NDGA, Tetra-O-methyl Nordihydroguaiaretic Acid, TMNDGA, Pharmacological Study, Pharnacological Study
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Erimos Pharmaceuticals, National Cancer Institute (NCI)
High Grade Glioma (III or IV)
09/23
10/23

Download Options